SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Marthe Fourcade
Retail
Novo Nordisk slides on pressure from Lilly’s pill study
By
Marthe Fourcade
and
Bloomberg
Health
Intermittent fasting linked to 91% increase in risk of death from heart disease, study says
By
Marthe Fourcade
and
Bloomberg
Health
Weight loss drugs are such big sellers now that Ozempic’s maker has overtaken LVMH as Europe’s most valuable company
By
Jonas Ekblom
,
Marthe Fourcade
, and others
Health
Getting vaccinated after infection can ease long COVID symptoms, large new study says
By
Marthe Fourcade
,
Clara Hernanz Lizarraga
, and others
Health
WHO official downplays COVID variant discovered in France
By
Marthe Fourcade
,
Thomas Mulier
, and others
Health
T cells fight off severe Omicron, says a new Dutch and South African study
By
Marthe Fourcade
,
Michelle Fay Cortez
, and others
Health
20% of severely ill patients with COVID in the U.K. are unvaccinated pregnant women
By
Marthe Fourcade
and
Bloomberg
Health
Johnson & Johnson to delay Europe vaccine rollout amid U.S. pause over six blood clot cases
By
Marthe Fourcade
,
Naomi Kresge
, and others
International
New COVID-19 vaccine data spotlights an unsung immune player: T cells
By
Jason Gale
,
Marthe Fourcade
, and others
Health
1 in 5 people are at risk of developing ‘severe’ COVID-19 symptoms due to underlying health conditions
By
Marthe Fourcade
and
Bloomberg
International
French doctors confirm COVID-19 case from December, throwing Europe outbreak timeline into question
By
Marthe Fourcade
and
Bloomberg
Health
In race to make a coronavirus vaccine, AstraZeneca joins forces with Oxford University
By
Marthe Fourcade
,
John Lauerman
, and others
International
What coronavirus hospital data tells us about ICU patients like Boris Johnson
By
John Lauerman
,
Marthe Fourcade
, and others
International
The 1-meter rule: virologists pan high fives, ‘bro hugs,’ and kissing as the coronavirus spreads
By
Thomas Mulier
,
Marthe Fourcade
, and others
International
Tiffany Agrees to Tie the Knot After LVMH Raises Its Bid to $16.2 Billion
By
Robert Williams
,
Marthe Fourcade
, and others